Abstract
Liver transplantation is indicated for rapidly progressing Budd–Chiari syndrome (BCS) after failure of conventional treatment. Outflow reconstruction is key in BCS cases. The area of the venous outflow obstruction varies among cases. The hepatic veins of the liver graft must be anastomosed with a patent outflow tract of the recipient. After transplantation, the 5-year survival rate of patients with BCS is approximately 75%. As patients with BCS are often in a prothrombotic state, long-term anticoagulation therapy should be maintained after liver transplantation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- BCS:
-
Budd–Chiari syndrome
- TIPS:
-
Transjugular intrahepatic portosystemic shunt
- HV:
-
Hepatic veins
- IVC:
-
Inferior vena cava
References
Valla DC. Primary Budd-Chiari syndrome. J Hepatol. 2009;50(1):195–203. https://doi.org/10.1016/j.jhep.2008.10.007.
DeLeve LD, Valla DC, Garcia-Tsao G. Vascular disorders of the liver. Hepatology. 2009;49(5):1729–64. https://doi.org/10.1002/hep.22772.
Ringe B, Lang H, Oldhafer KJ, Gebel M, Flemming P, Georgii A, et al. Which is the best surgery for Budd-Chiari syndrome: venous decompression or liver transplantation? A single-center experience with 50 patients. Hepatology. 1995;21(5):1337–44.
Halff G, Todo S, Tzakis AG, Gordon RD, Starzl TE. Liver transplantation for the Budd-Chiari syndrome. Ann Surg. 1990;211(1):43–9.
Darwish Murad S, Valla DC, de Groen PC, Zeitoun G, Haagsma EB, Kuipers EJ, et al. Pathogenesis and treatment of Budd-Chiari syndrome combined with portal vein thrombosis. Am J Gastroenterol. 2006;101(1):83–90. https://doi.org/10.1111/j.1572-0241.2006.00353.x.
Darwish Murad S, Valla DC, de Groen PC, Zeitoun G, Hopmans JA, Haagsma EB, et al. Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome. Hepatology. 2004;39(2):500–8. https://doi.org/10.1002/hep.20064.
Ara C, Akbulut S, Ince V, Karakas S, Baskiran A, Yilmaz S. Living donor liver transplantation for Budd-Chiari syndrome: overcoming a troublesome situation. Medicine. 2016;95(43):e5136. https://doi.org/10.1097/md.0000000000005136.
Pahari H, Chaudhary RJ, Thiagarajan S, Raut V, Babu R, Bhangui P, et al. Hepatic venous and inferior vena cava morphology no longer a barrier to living donor liver transplantation for Budd-Chiari syndrome: surgical techniques and outcomes. Transplant Proc. 2016;48(8):2732–7. https://doi.org/10.1016/j.transproceed.2016.08.009.
Dogrul AB, Yankol Y, Mecit N, Kanmaz T, Acarli K, Kalayoglu M. Orthotopic liver transplant for Budd-Chiari syndrome: an analysis of 14 cases. Exp Clin Transplant. 2016;14(6):641–5. https://doi.org/10.6002/ect.2015.0026.
Fukuda A, Ogura Y, Kanazawa H, Mori A, Kawaguchi M, Takada Y, et al. Living donor liver transplantation for Budd-Chiari syndrome with hepatic inferior vena cava obstruction after open pericardial procedures. Surg Today. 2013;43(10):1180–4. https://doi.org/10.1007/s00595-012-0440-1.
Menon KV, Shah V, Kamath PS. The Budd-Chiari syndrome. N Engl J Med. 2004;350(6):578–85. https://doi.org/10.1056/NEJMra020282.
Segev DL, Nguyen GC, Locke JE, Simpkins CE, Montgomery RA, Maley WR, et al. Twenty years of liver transplantation for Budd-Chiari syndrome: a national registry analysis. Liver Transpl. 2007;13(9):1285–94. https://doi.org/10.1002/lt.21220.
Mentha G, Giostra E, Majno PE, Bechstein WO, Neuhaus P, O’Grady J, et al. Liver transplantation for Budd-Chiari syndrome: a European study on 248 patients from 51 centres. J Hepatol. 2006;44(3):520–8. https://doi.org/10.1016/j.jhep.2005.12.002.
Campbell DA Jr, Rolles K, Jamieson N, O’Grady J, Wight D, Williams R, et al. Hepatic transplantation with perioperative and long term anticoagulation as treatment for Budd-Chiari syndrome. Surg Gynecol Obstet. 1988;166(6):511–8.
Cruz E, Ascher NL, Roberts JP, Bass NM, Yao FY. High incidence of recurrence and hematologic events following liver transplantation for Budd-Chiari syndrome. Clin Transplant. 2005;19(4):501–6. https://doi.org/10.1111/j.1399-0012.2005.00374.x.
Shaked A, Goldstein RM, Klintmalm GB, Drazan K, Husberg B, Busuttil RW. Portosystemic shunt versus orthotopic liver transplantation for the Budd-Chiari syndrome. Surg Gynecol Obstet. 1992;174(6):453–9.
Srinivasan P, Rela M, Prachalias A, Muiesan P, Portmann B, Mufti GJ, et al. Liver transplantation for Budd-Chiari syndrome. Transplantation. 2002;73(6):973–7.
Attwell A, Ludkowski M, Nash R, Kugelmas M. Treatment of Budd-Chiari syndrome in a liver transplant unit, the role of transjugular intrahepatic porto-systemic shunt and liver transplantation. Aliment Pharmacol Ther. 2004;20(8):867–73. https://doi.org/10.1111/j.1365-2036.2004.02190.x.
Ryu RK, Durham JD, Krysl J, Shrestha R, Shrestha R, Everson GT, et al. Role of TIPS as a bridge to hepatic transplantation in Budd-Chiari syndrome. J Vasc Interv Radiol. 1999;10(6):799–805.
Henderson JM, Nagle A, Curtas S, Geisinger M, Barnes D. Surgical shunts and TIPS for variceal decompression in the 1990s. Surgery. 2000;128(4):540–7. https://doi.org/10.1067/msy.2000.108209.
Eapen CE, Velissaris D, Heydtmann M, Gunson B, Olliff S, Elias E. Favourable medium term outcome following hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome. Gut. 2006;55(6):878–84. https://doi.org/10.1136/gut.2005.071423.
Potthoff A, Attia D, Pischke S, Mederacke I, Beutel G, Rifai K, et al. Long-term outcome of liver transplant patients with Budd-Chiari syndrome secondary to myeloproliferative neoplasms. Liver Int. 2015;35(8):2042–9. https://doi.org/10.1111/liv.12816.
Liu L, Qi XS, Zhao Y, Chen H, Meng XC, Han GH. Budd-Chiari syndrome: current perspectives and controversies. Eur Rev Med Pharmacol Sci. 2016;20(15):3273–81.
Janssen HL, Garcia-Pagan JC, Elias E, Mentha G, Hadengue A, Valla DC. Budd-Chiari syndrome: a review by an expert panel. J Hepatol. 2003;38(3):364–71.
Melear JM, Goldstein RM, Levy MF, Molmenti EP, Cooper B, Netto GJ, et al. Hematologic aspects of liver transplantation for Budd-Chiari syndrome with special reference to myeloproliferative disorders. Transplantation. 2002;74(8):1090–5. https://doi.org/10.1097/01.Tp.0000030635.57764.C1.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Sugawara, Y., Hibi, T. (2020). Liver Transplantation for Budd–Chiari Syndrome. In: Qi, X. (eds) Budd-Chiari Syndrome. Springer, Singapore. https://doi.org/10.1007/978-981-32-9232-1_14
Download citation
DOI: https://doi.org/10.1007/978-981-32-9232-1_14
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-32-9231-4
Online ISBN: 978-981-32-9232-1
eBook Packages: MedicineMedicine (R0)